Author:
Black Peter C.,Dinney Colin P. N.
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2007. CA Cancer J Clin, 2007, 57:43–66.
2. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, et al.: Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol 2000, 164:680–684.
3. Habuchi T, Marberger M, Droller MJ, et al.: Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology 2005, 66:64–74.
4. Rotterud R, Fossa SD, Nesland JM: Protein networking in bladder cancer: immunoreactivity for FGFR3, EGFR, ERBB2, KAI1, PTEN, and RAS in normal and malignant urothelium. Histol Histopathol 2007, 22:349–363.
5. Memon AA, Sorensen BS, Meldgaard P, et al.: The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients. Br J Cancer 2006, 94:1703–1709.
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献